Diabetes
Show Only Open Trials
1.
A Randomized, Multi-Center, Pivotal Efficacy and Safety Study Comparing the EndoBarrierĀ® Gastrointestinal Liner System vs. Sham for Glycemic Improvement in Inadequately Controlled Obese Type 2 Diabetic Subjects on Oral Anti-Diabetes Agents
- Study Status: Open to Enrollment
- Sponsor: GI Dynamics
- Disease Status and/or Stage: Overweight with Type 2 Diabetes